The carboxyl-terminal tsp1-homology domain is the biologically active effector peptide of matricellular protein ccn5 that counteracts profibrotic ccn2

HIGHLIGHTS

• who: Sima Zolfaghari from the Institute for Surgical Research, Oslo University Hospital, Oslo, Norway have published the Article: The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2, in the Journal: (JOURNAL)
• what: The aims of this study was to resolve to what extent the carboxyl-terminal TSP1 domain of CCN5 is a biologically active entity sufficient in conveying the signaling and biological actions of CCN5. Since CCN2 has previously been documented to be essential to the function of fibroblasts , 3 the authors focused on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.